Events
On February 9, Beijing Pharmaceutical centralized procurement service center, Tianjin pharmaceutical procurement center and Hebei medical equipment centralized procurement center jointly issued the work plan for the linkage procurement and use of orthopedic trauma medical consumables in the Beijing Tianjin Hebei "3 + n" alliance, Tianjin, Inner Mongolia Autonomous Region, Liaoning Province, Jilin Province, Heilongjiang Province, Zhejiang Province, Anhui Province A total of 17 provincial administrative units in Fujian Province, Shandong Province, Guangdong Province, Hainan Province, Sichuan Province, Tibet Autonomous Region, Shaanxi Province, Gansu Province, Xinjiang Uygur Autonomous Region and Xinjiang production and Construction Corps formed a Procurement Alliance to implement joint volume procurement of orthopedic trauma medical consumables.
Comments
The price linkage with the alliance of 12 provinces in Henan may further reduce the price of consumables. The scope covered by the "3 + n" alliance of Beijing, Tianjin and Hebei is large. Compared with the previous alliance of 12 provinces in Henan, it covers 29 provincial administrative units in China. At present, only Beijing, Shanghai and Jiangsu in China have not entered the volume Procurement Alliance, which means that orthopedic trauma consumables in most parts of the country will be reduced in 2022. Moreover, the "3 + n" alliance of Beijing, Tianjin and Hebei takes the form of linkage with the alliance of 12 provinces in Henan. The price of the previously selected products will be the upper limit of the supply price declared by the enterprise. During the procurement period, the price linkage will also be implemented for the selected products with lower price in other regions. In 2021, the average decline of products in the alliance of 12 provinces in Henan reached 88.65%. It is expected that the price of consumables may also decline significantly this time.
Enterprises provide quotations in stages to provide the basis for filling in and increasing the demand of medical institutions. The alliance's procurement with quantity adopts the form of twice declaring the supply price: before the medical institution reports the quantity, the enterprise must first provide the price of the products to be supplied, and the proposed supply price declared for the first time will be used as the basis for the medical institution to fill in the procurement demand. After calculating the intended purchase quantity of all purchasing entities, the enterprise shall fill in the actual supply price for the second time, but the actual supply price shall not be higher than the proposed supply price declared for the first time. Medical institutions will be able to fill in more reasonable purchase demand according to product quotation and their own characteristics.
The two-way selection determines the bid winning result, and the purchasing entity still retains a large option. In the final selection stage, the enterprise confirms the supply intention based on the purchase package according to the intended purchase quantity of the medical institution and its own supply capacity. After the enterprise confirms the supply, the two-way selection is successful. If both parties choose the product successfully, it is the selected product. The unselected quantity to be allocated is reassigned by the purchasing entity to other selected products in the same purchase package. For medical institutions, they still retain a large right to choose products, which is conducive to different medical institutions to make differentiated product choices according to their own characteristics, and enterprises can also choose the supply scope according to their own supply capacity.
The work flow of centralized purchase is compact, and the policy is expected to be implemented quickly. The specific process of the work plan of the alliance centralized purchase is divided into six steps: 1) determine the upper limit of supply price, 2) determine the declared products, 3) collect the historical procurement data and intended procurement volume of the purchasing subject, 4) the quotation of the declaring enterprise for the declared products, 5) the two-way selection between the declaring enterprise and the purchasing subject, and 6) sign an agreement. The first round of confirmation of the five-way selection will be completed before March 3, The overall process setting is relatively compact. According to the historical experience of inter provincial alliance with volume procurement in the past, it is expected that the final policy is expected to achieve rapid implementation in 2022 and quickly achieve the goal of reducing the burden of patients' medical expenses.
Investment advice
After the implementation of the "3 + n" alliance with volume procurement in Beijing, Tianjin and Hebei, the price of orthopaedic trauma consumables in most parts of China will be reduced. The decline of product terminal price will directly compress the falsely high profit space in the past distribution model, but manufacturers are expected to maintain a reasonable profit space, which is conducive to standardizing the procurement and use of consumables and improving the industry ecology. It is suggested to pay attention to the core competitive enterprises with complete product pipelines, strong R & D strength and certain brand strength in the orthopedic track.
Risk tips
The risk that the price decline of volume purchase exceeds the expectation; The risk of the enterprise falling short of the standard; The procurement volume of medical structure is lower than the expected risk.
